Skip to main content
Jafron Biomedical Co.,Ltd. logo

Jafron Biomedical Co.,Ltd. — Investor Relations & Filings

Ticker · 300529 ISIN · CNE100002995 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,842 across all filing types
Latest filing 2020-04-01 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300529

About Jafron Biomedical Co.,Ltd.

https://www.jafron.com

Jafron Biomedical Co.,Ltd. specializes in the research, development, and manufacturing of biomaterials and equipment for blood purification. The company is a primary provider of hemoperfusion technology, focusing on the production of adsorbent cartridges designed to remove specific toxins and inflammatory mediators from the bloodstream. Its core product portfolio includes the HA series of hemoperfusion cartridges, which are applied in clinical settings for end-stage renal disease, acute poisoning, critical care, and liver failure. Beyond consumables, the company develops blood purification machines and integrated treatment systems. These solutions target clinical applications in nephrology, intensive care, and hepatology. By leveraging advanced resin adsorption technology, the company provides specialized extracorporeal blood treatment options aimed at improving patient outcomes in complex medical conditions.

Recent filings

Filing Released Lang Actions
独立董事候选人声明（周凌宏）
Board/Management Information Classification · 95% confidence The document is a detailed declaration by an independent director candidate (周凌宏) for 健帆生物科技集团股份有限公司. It contains statements about the candidate's qualifications, compliance with relevant laws, regulations, and independence criteria required for serving as an independent director. There is no financial data, no discussion of company performance, no voting results, no meeting materials, and no mention of any report publication. The document is a formal declaration related to board/management information, specifically concerning the appointment or candidacy of a board member. Therefore, it fits best under the category of Board/Management Information (MANG). The document length is over 5,000 characters and contains substantive content, not just an announcement or certification, so it is not RNS or RPA.
2020-04-01 Chinese
独立董事提名人声明（三）
Board/Management Information Classification · 100% confidence The document is a public statement from the board of directors nominating an individual as an independent director candidate for the company's board. It details the nominee's qualifications, compliance with various regulatory requirements, and declarations regarding independence and eligibility. There is no financial data, earnings information, or report publication mentioned. The content is focused on board/management changes, specifically the nomination of a board member. Therefore, the document fits the category of Board/Management Information (MANG). The document length is sufficient and contains detailed statements about the nominee's qualifications and compliance, confirming it is not a brief announcement but a substantive declaration related to board management.
2020-04-01 Chinese
2019年度独立董事述职报告（周凌宏）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Work Report for 2019" from a specific independent director of the company. It details the director's attendance at board and shareholder meetings, participation in board committees, opinions on various board matters, on-site investigations, investor protection activities, and training. The content is a detailed report of the independent director's duties and activities during the year 2019. It is not an annual report, audit report, or any other financial statement. It is a management-related report focusing on governance and director activities. Therefore, the document fits best under the category of Board/Management Information (MANG), which covers announcements or reports related to board or senior management activities and changes. The document length is 3812 characters, which is consistent with a detailed report but not a full annual report or financial statement. Hence, the classification is MANG with high confidence.
2020-04-01 Chinese
2019年度独立董事述职报告（崔松宁）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Work Report for 2019" from a specific independent director of the company. It details the director's attendance at board and shareholder meetings, participation in board committees, independent opinions on various company matters, on-site investigations, investor protection activities, training, and other related duties during the year 2019. The content is a detailed narrative report on the director's activities and opinions rather than a financial report, earnings release, or regulatory filing. It is not an announcement of voting results or a proxy solicitation. It is a management-related report focusing on governance and oversight activities by an independent director. This fits best under the category of Board/Management Information (MANG), which includes announcements or reports related to board members and senior management activities. The document length is under 5,000 characters, but it is a substantive report, not a mere announcement of a report publication. Therefore, the classification is MANG with high confidence.
2020-04-01 Chinese
2019年度监事会工作报告
Management Reports Classification · 95% confidence The document is titled as the "2019年度监事会工作报告" which translates to the "2019 Supervisory Board Work Report" of the company. It details the supervisory board's activities, meetings, opinions on the company's legal compliance, financial status, internal controls, and plans for 2020. It includes references to audit reports but does not itself contain full financial statements or detailed financial data. The document is a report from the supervisory board summarizing oversight activities rather than a full annual report or audit report. It is not a short announcement or certification but a substantive report on supervisory activities. Therefore, it fits best under the category of Management Reports (MDA), which covers management's detailed explanation of financial results, business trends, and outlook, including supervisory board reports.
2020-04-01 Chinese
关于拟续聘2020年度审计机构的公告
Regulatory Filings Classification · 90% confidence The document is an announcement regarding the proposed reappointment of the audit firm for the fiscal year 2020. It details the audit firm's background, qualifications, personnel, and the procedures followed for the reappointment, including board and independent director opinions. The document does not contain actual audit reports or financial statements but is a formal announcement about the audit firm appointment for the upcoming audit period. The document length is 3572 characters, which is relatively short and consistent with an announcement rather than a full audit report. Therefore, this document fits best under the category of Audit Report / Information (AR) as it relates to audit firm appointment and audit-related information but is not a full annual report or audit report itself. However, given the short length and nature as an announcement of audit firm reappointment, it is more appropriate to classify it as Regulatory Filings (RNS) because it is an announcement about audit firm appointment rather than the audit report itself.
2020-04-01 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.